Advertisement
Person › Details
Malcolm Weir (Heptares Therapeutics Ltd. (Sosei Heptares))
Weir, Malcolm (Heptares 2007– CEO + co-founder before Inpharmatica 2000–2006 CEO before GSK/Glaxo since 1983)
Organisation | Heptares Therapeutics Ltd. (Sosei Heptares) | |
Group | Sosei (Group) | |
Former/major organisation | Inpharmatica Ltd. | |
Product | GPCR inhibitor | |
Product 2 | drug discovery | |
Record changed: 2019-08-07 |
Advertisement
More documents for Malcolm Weir
- [1] Sosei Group Corporation (d/b/a Sosei Heptares). (8/5/19). "Press Release: Sosei Heptares and Takeda Enter into New Strategic Multi-target Research, Development and Commercialization Partnership". Tokyo & London....
- [2] Sosei Group Corporation (d/b/a Sosei Heptares). (7/16/19). "Press Release: Sosei Heptares Enters into Multi-target Research Collaboration and License Agreement with Genentech". Tokyo & London....
- [3] Sosei Group Corporation (d/b/a Sosei Heptares). (2/4/19). "Press Release: Sosei Heptares Announces Medicxi to Invest up to €40 Million in New Collaboration Based on Its Orexin Agonist Program". Tokyo & London....
- [4] Heptares Therapeutics Ltd.. (1/10/18). "Press Release: Sosei Subsidiary, Heptares, Enters Drug R&D Collaboration with Imperial College London Focused on Multiple GPCR Disease Target Opportunities in the Gastro-intestinal Tract". Tokyo & London....
- [5] Sosei Group Corporation. (5/18/17). "Press Release: Sosei Subsidiary Heptares to Receive US$5 Million Milestone Payment from Teva". Tokyo....
- [6] Heptares Therapeutics Ltd.. (3/13/17). "Press Release: Heptares Enters Agreement with Daiichi Sankyo to Discover and Develop Novel, Small Molecules for the Treatment of Pain". London....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top